Trial to Investigate GZ21T in Healthy Volunteers

NCT06888362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: GZ21T

Sponsor

Genzada Pharmaceuticals USA, Inc.

Collaborators

CTC Clinical Trial Consultants AB